-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 18, the medical device sector was active, and from the perspective of individual stocks, many stocks closed up more than 10%, including Libon Instruments, Baolaite, Shangrong Medical also rose nearly 10%, and Hotjing Biotechnology, Lude Medical, Lanwei Medical, Weiss Medical, etc.
rose by more than 5%.
As of the close on October 18, Libon Instruments rose by about 15%, with a quotation of 15.
15 yuan, a turnover of 965 million, a turnover rate of 18.
44%, a price-to-earnings (TTM) of 51.
73, and a total market value of 8.
813 billion
.
Leebang Instruments is mainly engaged in the research and development, production, sales and service
of medical electronic equipment products and in vitro diagnostic products.
It mainly covers more than 100 models
in five fields: maternal and child health care products and systems, multi-parameter monitoring products and systems, ECG products and systems, digital ultrasound diagnosis systems, and in vitro diagnosis.
The company adheres to the development strategy
of "innovation, platform and internationalization".
Among them, in the field of medical electronic equipment, the company is mainly engaged in the research and development, production and sales of medical electronic equipment, and provides more than 80 models of products
in four major fields: obstetrics, ECG, monitoring and ultrasound imaging.
In terms of research and development, the company's main products have independent intellectual property rights, master core technologies such as physiological signal detection, medical transducers, and main control platforms, and have the ability to
develop serial and information-based products.
Bolite closed up 12.
28% on the 18th, with a quotation of 18.
29 yuan, a turnover of 577 million, a turnover rate of 22.
07%, a price-to-earnings (TTM) of 697.
51, and a total market value of 3.
213 billion
.
The company is a company whose main business is the research and development, production, sales and service of medical device products, mainly covering two major business segments
: health monitoring and renal medical care.
Among them, in the health monitoring sector, mainly for medical monitoring equipment and supporting products, the main products are monitor equipment, electrocardiogram machine, pulse oximeter, central monitoring system, wearable medical products, etc.
, widely used in family health care, community medicine, general ward, emergency room, hyperbaric oxygen chamber, ICU, CCU, operating room and other fields
。 In the medical sector of nephrology, it is mainly hemodialysis products, the main products are hemodialysis equipment (machine), hemodialyzer, hemodialysis powder/dialysate, perfusion machine, hemodialysis pipeline, puncture needle, disinfectant, dialysis water equipment, disinfection system, concentrated solution centralized distribution and supply system and other products, which are widely used in the treatment
of acute and chronic renal failure.
On the news, the National Health Commission recently said that it would continue to strengthen the construction of designated hospitals, and required all localities to designate hospitals with strong comprehensive capacity and high treatment level as designated hospitals
.
Designated hospitals should be equipped with sufficient beds for treatment according to the size of the local population, and at the same time, the construction of intensive care units, that is, ICUs, should be strengthened, and ICU beds should reach 10%
of the total number of beds.
The industry believes that with the release of these optimization measures, the number of ICU beds will increase, and at the same time, medical equipment such as ventilators, monitors, infusion pumps, etc.
are also expected to usher in greater growth space, driving the growth
of related companies' performance.
From the perspective of the entire medical device industry, after years of development, China's medical device industry has initially built an industrial system
with complete professional categories, perfect industrial chain and strong industrial foundation.
With the development of the economy, the growth of the population, the improvement of the aging of society, and the continuous enhancement of people's awareness of health care, the demand for medical devices in China continues to grow rapidly, and the industrial development space is broad
.
And with the advancement of new medical infrastructure, the industry believes that the trend of localization of medical equipment is expected to accelerate
.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.